GILD vs MXL · P/E 18, rev $7.80B vs rev $306.0M
Gilead Sciences Inc (GILD) versus MaxLinear Inc (MXL) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MXL revenue for 2026-06-30 was $306.0M. Net income was -$43.4M. MXL currently screens at market cap $7.42B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MXL currently screens at market cap $7.42B.
Not investment advice. Open the GILD and MXL stock pages for the full models.
Not investment advice.